Who has invested in Best-Link Bioscience?

Hyfinity Investments are named among the investors backing Best-Link Bioscience.

Best-Link Bioscience Funding: $153M Raised, Series C (2026)

Best-Link Bioscience funding overview

Best-Link Bioscience is based in Shanghai, China. Best-Link Bioscience has raised $153M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2026. The round record for Best-Link Bioscience runs through 2026; nothing later has been disclosed. Investors on record include Hyfinity Investments.

Best-Link Bioscience at a glance

Total raised: $153M
Latest round: Series C
Latest round date: May 2026
Headquarters: Shanghai, China
Notable investors: Hyfinity Investments

Frequently asked about Best-Link Bioscience funding

How much has Best-Link Bioscience raised?: Best-Link Bioscience has raised $153M in total disclosed funding across the rounds on record.
Who has invested in Best-Link Bioscience?: Hyfinity Investments are named among the investors backing Best-Link Bioscience.
What was the latest Best-Link Bioscience funding round?: The most recent disclosed round is a Series C, announced in May 2026.
Where is Best-Link Bioscience based?: Best-Link Bioscience is based in Shanghai, China.
When did Best-Link Bioscience last raise?: The last disclosed Best-Link Bioscience round closed in May 2026 at Series C.

Best-Link Bioscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

Best-Link Bioscience Funding: $153M Raised, Series C (2026)

Best-Link Bioscience funding overview

Best-Link Bioscience at a glance

Frequently asked about Best-Link Bioscience funding

Companies related to Best-Link Bioscience (18)

Browse related funding lists (5)